Back
Aura Biosciences Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
14
AURA
Aura Biosciences
Last Price:
9.54
Seasonality Move:
-16.2%
Sell
29
NBY
NovaBay Pharmaceuticals
Last Price:
0.51
Seasonality Move:
-14.79%
Sell
14
Aura Biosciences (AURA)
is a Sell
Is Aura Biosciences a Buy, Sell or Hold?
- The current Aura Biosciences [AURA] share price is $9.57. The Score for AURA is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
- AURA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
29
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.53. The Score for NBY is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AURA Stock Price Chart
What is Aura Biosciences's stock price today?
-
The Aura Biosciences share price today is $9.57
The current trend is moderately bullish and AURA is experiencing selling pressure, which indicates risk of future bearish movement.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.53
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
AURA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.39 | Buy |
Relative Strength Index (14 RSI): | 62.35 | Buy |
Chaikin Money Flow: | -109036 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.41 - 9.03) | Buy |
Bollinger Bands (100): | (7.02 - 8.88) | Buy |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.11 | Sell |
Relative Strength Index (14 RSI): | 40.27 | Sell |
Chaikin Money Flow: | 161961 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.47 - 0.53) | Buy |
Bollinger Bands (100): | (0.64 - 3.4) | Sell |
AURA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.16 | Buy |
20-day SMA: | 8.27 | Buy |
50-day SMA: | 8.61 | Buy |
200-day SMA: | 8.07 | Buy |
8-day EMA: | 9.26 | Buy |
20-day EMA: | 8.7 | Buy |
50-day EMA: | 8.39 | Buy |
200-day EMA: | 8.39 | Buy |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.48 | Buy |
20-day SMA: | 0.49 | Buy |
50-day SMA: | 0.93 | Sell |
200-day SMA: | 3.89 | Sell |
8-day EMA: | 0.49 | Buy |
20-day EMA: | 0.53 | Sell |
50-day EMA: | 0.99 | Sell |
200-day EMA: | 8.5 | Sell |
Aura Biosciences Earnings Growth & AURA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $13.87 per share, an increase next quarter of $0.05 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.
Aura Biosciences Technical Analysis
Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |